Clinical Report: Evaluating the Effectiveness and Safety of Combined Medical and Surgical Approaches for Hidradenitis Suppurativa
Overview
This systematic review evaluates the efficacy and safety of combining immunomodulatory therapy with surgical interventions in patients with hidradenitis suppurativa (HS).
Background
Hidradenitis suppurativa is a chronic inflammatory skin disorder that significantly affects patients' quality of life. Current treatment strategies include both medical and surgical options, but the optimal approach for moderate-to-severe cases remains unclear. This study addresses the need for systematic evaluation of combined treatment strategies.
Data Highlights
No specific numerical data or trial data was provided in the source material.
Key Findings
Combination therapy was associated with improved clinical outcomes, including higher response rates (HiSCR score, IHS4-55 score).
Patients experienced reductions in pain, flares, and Dermatology Life Quality Index (DLQI) scores.
No consistent increase in adverse events was observed compared to biologic monotherapy.
Conclusions are limited by low-quality, heterogeneous evidence.
There is a need for well-designed prospective studies.
Clinical Implications
Further research is needed to establish definitive treatment protocols for managing hidradenitis suppurativa.
Conclusion
The systematic review highlights the need for further high-quality studies to validate findings regarding combined therapies for hidradenitis suppurativa.
